The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population

Parkinsonism and Related Disorders

Volumn 16, Issue 2, 2010, Pages 85-88

  Kim, Jong Min ^a   Lee, Jee Young ^b   Kim, Hee Jin ^a   Kim, Ji Seon ^a   Shin, Eun Soon ^c   Cho, Jin Hwan ^a   Park, Sung Sup ^a   Jeon, Beom S ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Inje University   (South Korea)

^c DNA Link Inc   (South Korea)

Author keywords

G2385R; LRRK2; Parkinson's disease; Polymorphism; R1628P

Indexed keywords

ARGININE; ENZYME VARIANT; GLYCINE; LEUCINE RICH REPEAT KINASE 2; PROLINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ARGININE; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCINE; HUMANS; KOREA; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; YOUNG ADULT;

EID: 75949122054     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.10.004     Document Type: Article

References (31)

1. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 4 (2004) 595-600
2. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 4 (2004) 601-607
3. Nichols W.C., Pankratz N., Hernandez D., Paisán-Ruíz C., Jain S., Halter C.A., et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 9457 (2005) 410-412
4. Di Fonzo A., Rohé C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 9457 (2005) 412-415
5. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 9457 (2005) 415-416
6. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76 4 (2005) 672-680
7. Lesage S., Dürr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354 4 (2006) 422-423
8. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354 4 (2006) 424-425
9. Tan E.K., Shen H., Tan L.C., Farrer M., Yew K., Chua E., et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 384 3 (2005) 327-329
10. Tomiyama H., Li Y., Funayama M., Hasegawa K., Yoshino H., Kubo S., et al. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. Mov Disord 21 8 (2006) 1102-1108
11. Zabetian C.P., Morino H., Ujike H., Yamamoto M., Oda M., Maruyama H., et al. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Neurology 67 4 (2006) 697-699
12. Cho J.W., Kim S.Y., Park S.S., Kim H.J., Ahn T.B., Kim J.M., et al. The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease. Can J Neurol Sci 34 1 (2007) 53-55
13. Cho J.W., Kim S.Y., Park S.S., and Jeon B.S. The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease and multiple system atrophy. J Clin Neurol 5 (2009) 29-32
14. Mata I.F., Kachergus J.M., Taylor J.P., Lincoln S., Aasly J., Lynch T., et al. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 6 4 (2005) 171-177
15. Di Fonzo A., Tassorelli C., De Mari M., Chien H.F., Ferreira J., Rohé C.F., et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 14 3 (2006) 322-331
16. Di Fonzo A., Wu-Chou Y.H., Lu C.S., van Doeselaar M., Simons E.J., Rohé C.F., et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 7 3 (2006) 133-138
17. Farrer M.J., Stone J.T., Lin C.H., Dächsel J.C., Hulihan M.M., Haugarvoll K., et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 13 2 (2007) 89-92
18. Funayama M., Li Y., Tomiyama H., Yoshino H., Imamichi Y., Yamamoto M., et al. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport 18 3 (2007) 273-275
19. Tan E.K., Zhao Y., Skipper L., Tan M.G., Di Fonzo A., Sun L., et al. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet 120 6 (2007) 857-863
20. Zabetian C.P., Yamamoto M., Lopez A.N., Ujike H., Mata I.F., Izumi Y., et al. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord 24 7 (2009) 1034-1041
21. Ross O.A., Wu Y.R., Lee M.C., Funayama M., Chen M.L., Soto A.I., et al. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 64 1 (2008) 88-92
22. Tan E.K., Tan L.C., Lim H.Q., Li R., Tang M., Yih Y., et al. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence. Hum Genet 124 3 (2008) 287-288
23. Tan E.K., Tang M., Tan L.C., Wu Y.R., Wu R.M., Ross O.A., et al. Lrrk2 R1628P in non-Chinese Asian races. Ann Neurol 64 4 (2008) 472-473
24. Zhang Z., Burgunder J.M., An X., Wu Y., Chen W., Zhang J., et al. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China. Mov Disord (11 Aug 2009) 10.1002/mds.22371 published online
25. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
26. Kim J.M., Hong S., Kim G.P., Choi Y.J., Kim Y.K., Park S.S., et al. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol 64 (2007) 1510-1518
27. Ahn T.B., Kim S.Y., Kim J.Y., Park S.S., Lee D.S., Min H.J., et al. α-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70 (2008) 43-49
28. Kim J.Y., Kim S.Y., Kim J.M., Kim Y.K., Yoon K.Y., Kim J.Y., et al. Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism. Neurology 72 (2009) 1385-1389
29. Choi J.M., Woo M.S., Ma H.I., Kang S.Y., Sung Y.H., Yong S.W., et al. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 9 (2008) 263-269
30. Tan E.K., Peng R., Wu Y.R., Wu R.M., Wu-Chou Y.H., Tan L.C., et al. LRRK2 G2385R modulates age at onset in Parkinson's disease: a multi-center pooled analysis. Am J Med Genet B Neuropsychiatr Genet 150B 7 (2009) 1022-1023
31. Mata I.F., Wedemeyer W.J., Farrer M.J., Taylor J.P., and Gallo K.A. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci 29 5 (2006) 286-293